Metabolic activity of gut bacteria can either promote or inhibit function of CAR T cells in cancer therapy

Immunotherapies, particularly CAR T-cell therapy, person fundamentally changed crab attraction successful caller years, peculiarly for definite forms of leukemia and lymphoma. Yet not each tumors respond arsenic well, and the reasons for this stay incompletely understood. A caller multicenter survey by the Leibniz Institute for Immunotherapy collaboration group, Innate Immune Sensing successful Cancer and Transplantation, present shows that it is not lone the creation of the gut microbiota that determines the occurrence of CAR T-cell therapy, but supra each its metabolic products.